136,015 Shares in Envista Holdings Corporation $NVST Purchased by Evolve Private Wealth LLC

Evolve Private Wealth LLC bought a new stake in Envista Holdings Corporation (NYSE:NVST) in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 136,015 shares of the company’s stock, valued at approximately $3,584,000.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Millennium Management LLC boosted its stake in shares of Envista by 1,442.7% during the 4th quarter. Millennium Management LLC now owns 2,420,615 shares of the company’s stock worth $52,552,000 after purchasing an additional 2,263,712 shares during the last quarter. Holocene Advisors LP acquired a new position in shares of Envista in the second quarter valued at approximately $43,936,000. Arrowstreet Capital Limited Partnership raised its position in shares of Envista by 341.5% in the first quarter. Arrowstreet Capital Limited Partnership now owns 2,858,293 shares of the company’s stock valued at $72,515,000 after buying an additional 2,210,847 shares during the last quarter. Norges Bank purchased a new position in shares of Envista during the fourth quarter valued at approximately $45,113,000. Finally, Alliancebernstein L.P. lifted its stake in shares of Envista by 34.0% during the second quarter. Alliancebernstein L.P. now owns 6,098,445 shares of the company’s stock valued at $119,164,000 after buying an additional 1,547,656 shares during the period.

Envista Stock Performance

Shares of NVST stock opened at $27.21 on Friday. The company has a current ratio of 2.43, a quick ratio of 2.07 and a debt-to-equity ratio of 0.47. The company has a market cap of $4.37 billion, a PE ratio of 46.91, a P/E/G ratio of 1.30 and a beta of 0.86. The company’s fifty day simple moving average is $26.90 and its 200-day simple moving average is $26.28. Envista Holdings Corporation has a 52 week low of $18.77 and a 52 week high of $30.42.

Envista (NYSE:NVST) last released its quarterly earnings data on Wednesday, August 5th. The company reported $0.41 EPS for the quarter, beating the consensus estimate of $0.34 by $0.07. Envista had a return on equity of 7.88% and a net margin of 3.33%.The company had revenue of $730.50 million for the quarter, compared to analyst estimates of $716.11 million. During the same period last year, the company posted $0.26 earnings per share. The firm’s revenue was up 7.1% compared to the same quarter last year. Envista has set its FY 2026 guidance at 1.500-1.550 EPS. As a group, equities research analysts anticipate that Envista Holdings Corporation will post 1.53 EPS for the current year.

Wall Street Analyst Weigh In

NVST has been the subject of several analyst reports. Mizuho set a $29.00 price target on Envista in a report on Thursday, August 6th. Robert W. Baird set a $34.00 price objective on Envista in a research report on Thursday, August 6th. BMO Capital Markets started coverage on Envista in a research note on Wednesday, July 8th. They issued a “market perform” rating and a $27.00 target price for the company. Morgan Stanley set a $23.00 target price on Envista in a research note on Thursday, August 6th. Finally, Weiss Ratings raised Envista from a “hold (c-)” rating to a “hold (c)” rating in a research note on Thursday, August 6th. One investment analyst has rated the stock with a Strong Buy rating, six have given a Buy rating and nine have assigned a Hold rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $29.31.

Envista Company Profile

Envista Holdings Corporation is a global dental products company that develops, manufactures and markets a broad portfolio of dental consumables, equipment and technology solutions. Headquartered in Brea, California, Envista serves dental practitioners, specialists and laboratories in more than 150 countries. The company’s offerings span implant, orthodontic, endodontic and restorative product lines as well as digital imaging systems and practice management software.

Envista’s product brands include Nobel Biocare for dental implants and restorative solutions, Ormco for orthodontic appliances and treatment systems, Kerr for restorative and endodontic materials, KaVo for dental imaging and handpieces, and Vista for surgical drills and instruments.